The voltage-dependent potassium channel Kv1.3 plays essential physiological functions in the immune system. Kv1.3, regulating the membrane potential, facilitates downstream Ca 2+ -dependent pathways and becomes concentrated in specific membrane microdomains that serve as signaling platforms. Increased and/or delocalized expression of the channel is observed at the onset of several autoimmune diseases. In this work, we show that adenosine (ADO), which is a potent endogenous modulator, stimulates PKC, thereby causing immunosuppression. PKC activation triggers down-regulation of Kv1.3 by inducing a clathrin-mediated endocytic event that targets the channel to lysosomal-degradative compartments. Therefore, the abundance of Kv1.3 at the cell surface decreases, which is clearly compatible with an effective anti-inflammatory response. This mechanism requires ubiquitination of Kv1.3, catalyzed by the E3 ubiquitin-ligase Nedd4-2. Postsynaptic density protein 95 (PSD-95), a member of the MAGUK family, recruits Kv1.3 into lipid-raft microdomains and protects the channel against ubiquitination and endocytosis. Therefore, the Kv1.3/PSD-95 association fine-tunes the antiinflammatory response in leukocytes. Because Kv1.3 is a promising multi-therapeutic target against human pathologies, our results have physiological relevance. In addition, this work elucidates the ADOdependent PKC-mediated molecular mechanism that triggers immunomodulation by targeting Kv1.3 in leukocytes.
, ADO stabilizes KATP channels at the membrane surface in a PKC-dependent manner 23 . With this debate in mind, we investigated whether the modulation of Kv1.3 was consequence of a specific PKC-mediated endocytosis. HEK-293 cells, similarly to macrophages [24] [25] [26] , endogenously express the A 2B subtype of adenosine receptors 27 . Therefore, this cell line is a good model for dissecting the ADO-dependent PKC signaling.
We further analyzed the participation of a PKC-dependent mechanism by using the PKC agonist phorbol 12-myristate 13-acetate (PMA). The presence of the PKC inhibitor bisindolylmaleimide (BIM) hampered the internalization of channels ( Fig. 2A-D ,G), indicating that ADO triggered Kv1.3 endocytosis via stimulation of PKC. Similarly, specific PMA-dependent PKC activation also promoted the redistribution of Kv1.3 from the cell surface to vesicular structures ( Fig. 2E-G) . BIM abolished this effect, indicating that, similar to ADO-induced endocytosis, PMA-associated endocytosis was dependent on PKC (Fig. 2B,D ,F,G). This mechanism was indeed concomitant to an activation of the PKC. We analyzed the phosphorylation of PKCε because this isoform participates in TNF-α -dependent pro-inflammatory responses in HEK cells 28 and during the LPS-induced and MCSF-dependent activation in macrophages [29] [30] [31] . ADO ( Fig. 2H ) and PMA ( Fig. 2I ) augmented the phosphorylation of PKCε (~2 fold increase), without changes in total PKC. Again BIM effectively hampered (~50% decrease) PKC phosphorylation in both cases. Next, we monitored the time-course of Kv1.3 distribution under persistent PKC activation. PMA steadily induced the endocytosis of Kv1.3 (p < 0.0001, One-way ANOVA), which was almost completely internalized within 30 minutes (Fig. 2J-N) . Supporting HEK 293 cells, similar mechanisms functioned in mononuclear phagocytes (see Fig. 1 ), because a 30 min incubation with ADO ( Fig. 3O-Q) vesicularized Kv1.3 in CY15 dendritic cells.
The "antibody-feeding assay" was essential to unequivocally decipher the PKC-dependent endocytosis of the dopamine transporter (DAT) and the EGFR-dependent internalization of Kv1.3 4, 21 . HA-Kv1.3-YFP channels that simultaneously contain an extracellular HA tag and an intracellular YFP fluorophore were expressed in HEK-293 cells. Total (YFP) and extracellular (Cy5) Kv1.3 channels were observed under non-permeabilizing conditions. In the absence of PMA, cells showed surface HA-Kv1.3-YFP channels when stained with Cy5-labeled anti-HA antibodies (Fig. S1A,B ). In addition, some Cy3-labeled intracellular vesicles were also observed (Fig. S1C ). Because Kv1.3 recycling is rapid, this would correspond to constitutively internalized HA-Kv1.3-YFP channels in early endosomes. PMA increased intracellular Kv1.3-containing Cy3-stained vesicles (Fig. S1G ). Intracellular channels were inaccessible to Cy5-labeled secondary antibodies applied to non-permeabilized cells, both a decrease in extracellular Cy5 channels and an increase in internal Cy3-stained channels were observed upon PKC activation ( Fig. S1E-H) .
We next analyzed whether the Kv1.3 internalization was associated with changes in Kv currents in Kv1.3-YFP stable HEK-293 cells. Depolarizing pulses elicited K + currents, and 30 min incubation with PMA reduced those currents by 49%. BIM counteracted this effect, demonstrating a specific dependence on the PKC stimulation Scientific RepoRts | 7:42395 | DOI: 10.1038/srep42395 (Fig. 3A) . The I-V plots showed that PKC activation efficiently reduced current densities at all activation voltages ( Fig. 3B ) (p < 0.001, two-way ANOVA). We further analyzed the specific Kv1.3 C-type inactivation ( Fig. 3C-F) . This hallmark, which is the result of the cooperative interaction of all subunits within the complex, remained unaltered 32 . Thus, the τ of current decay (in ms) was similar being 720 ± 14, 698 ± 14, 742 ± 30 and 741 ± 11 for Control (Fig. 3C) , PMA (Fig. 3D ), Control + BIM (Fig. 3E ) and PMA + BIM (Fig. 3F) respectively. Taken together, these results further supported the down-regulation of Kv1.3, mostly governed by a PKC-mediated decrease of channel subunits at the cell surface, rather than major changes in Kv1.3 biophysics upon PKC activation.
PKC-dependent Kv1.3 endocytosis is a clathrin-mediated mechanism. We next dissected the mechanisms of PKC-dependent Kv1.3 endocytosis (Fig. 4) . After 5 minutes of PMA incubation, Kv1.3 colocalized with AP2 (Adaptor-related Protein complex 2) and Clathrin, components of the clathrin-coated pit (CCP) internalization machinery (Fig. 4A-H) . Thus, a pixel by pixel analysis indicated that Kv1.3 followed a intracellular pattern that overlaid with that of Clathrin and AP2 (Fig. 4D,H) . To further decipher this mechanism, stable Kv1.3 HEK cells were transfected with siRNAs against dynamin II (Dyn II) and Clathrin ( Fig. 4I-Q) , both crucial for the EGFR-mediated clathrin-dependent endocytosis of Kv1.3 4 . Under effective Clathrin and Dyn II depletion (Fig. 4I,J ), cells were incubated without (Fig. 4K-M) or with ( Fig. 4N-P) PMA for 30 min. Unlike mock treated cells, no significant PMA-dependent internalization of Kv1.3 was observed in Clathrin-or Dyn II-depleted cells (Fig. 4Q ). Clathrin and Dyn II also participate in the exocytic pathway of membrane proteins 33 ; therefore, some perinuclear Kv1.3 accumulation was observed (arrowheads in Fig. 4L ,M,O,P). Altogether, this evidence supports that CCP-mediated endocytosis was the main pathway for PKC-dependent Kv1.3 internalization.
Kv1.3 is targeted to sphingolipid-and cholesterol-enriched lipid rafts 34 . Caveolae/raft-dependent endocytosis upon PKC stimulation may be relevant for some ion channels located in such specialized microdomains 35 . Therefore, we investigated whether this endocytic mechanism was also involved in the PKC-dependent Kv1.3 internalization. Filipin and Nystatin inhibit lipid raft-and caveolae-dependent internalization 36 . However, neither treatment affected the PKC-dependent Kv1.3 endocytosis (Fig. S2A-C ,E-G). In addition, lipid rafts are profoundly affected by cholesterol-modifying agents such as methyl-β -cyclodextrin (Mβ CD) 34 . Although Mβ CD alters the raft targeting of Kv1.3, it did not affect the endocytosis of Kv1.3 ( Fig. S2D,H) . To further exclude the involvement of caveolae-dependent internalization, we used a caveolin 1-null (Cav1 − ) HEK-293 cell line 12 .
Whether Cav1
− cells were treated with or without Mβ CD, Kv1.3 always underwent endocytosis in the presence of PMA (Fig. S2I-L) . Therefore, PKC-dependent Kv1.3 endocytosis is a clathrin-mediated but caveolin-independent mechanism.
PSD-95 association stabilizes Kv1.3 at membrane raft microdomains and prevents PKC-mediated channel endocytosis. PKC and Kv1.3 are recruited into the IS, fine-tuning the T-cell activation 10, 11 . Moreover, the IS concentrates lipid raft microdomains as signaling platforms 10 . Kv1.3 interacts with proteins from the MAGUK family such as PSD-95, which recruits the channel into the IS 37 . Impaired IS localization of Kv1.3 is associated with lupus erythematosus 38 . Therefore, PKC-mediated internalization of Kv1.3 would affect the immune response. Thus, we analyzed whether PSD-95 protects Kv1.3 against PKC-dependent endocytosis. PSD-95 associated with Kv1.3 in HEK-293 cells (Fig. 5A ), affecting the channel membrane distribution ( Fig. 5B-J ). Kv1.3 evenly decorated the cell membrane (Fig. 5B,F) , whereas the presence of PSD-95 induced the formation of discrete clusters that colocalized with lipid raft markers ( Fig. 5F-J ). To further demonstrate the effect of PSD-95 on the cell membrane targeting of Kv1.3, we performed fluorescence recovery after photobleaching (FRAP) experiments in the presence of PSD-95 ( Fig. 5K-Q) . FRAP values indicated that the presence of PSD-95 increased about 2-fold the half-life (p < 0.01) and decreased by 50% the mobile fraction (p < 0.001) of Kv1.3 ( Fig. 5O-Q) . These results suggested that PSD-95 recruited Kv1.3 to less-mobile membrane microdomains.
Because PSD-95 redistributed Kv1.3 at the cell surface, we next analyzed whether PSD-95 could modify the PKC-dependent Kv1.3 internalization. PMA shifted Kv1.3 out of low-buoyancy fractions, suggesting that the CCP internalization delocalized the channel from lipid raft microdomains ( Fig. 6A,P) . However, PSD-95 To further demonstrate that PSD-95 protected Kv1.3 against PKC-dependent endocytosis, we used the HA-Kv1.3-YFP channel. In this experiment, while PMA elevated Kv1.3-YFP-positive intracellular vesicles, it almost completely abolished Kv1.3-HA extracellular staining ( Fig. S3A-F) . However, the presence of PSD-95 prevented the loss of the Kv1.3 extracellular HA signaling ( Fig. S3G-N Kv1.3 interacts with PSD-95 through a C-terminal PDZ-binding domain, defined by the last three residues of the channel (Thr 523 -Asp 524 -Val 525 ) 37 . Therefore, we used Kv1.3(T523X), a truncated channel that lacks this motif and thus cannot bind PSD-95 37 . Consequently, PSD-95 did not protect Kv1.3(T523X) from targeting out of floating-raft-enriched fractions upon PKC-dependent stimulation ( Fig. 6I,P) . Moreover, Kv1.3(T523X) did not cluster in the presence of PSD-95 under basal conditions, and it underwent PKC-dependent internalization (Fig. 6J -O, circled cell).
PKC-dependent Kv1.3 endocytosis targeted the channel for lysosomal degradation. Our results in macrophages and CY15 dendritic cells suggested that the abundance of Kv1.3 was decreased under ADO-dependent PKC stimulation (Fig. 1) . Therefore, to study in more detail whether Kv1.3 clathrin-mediated internalization ends in a lysosomal-associated degradative intracellular compartment, the PKC-dependent Kv1.3 endocytic mechanisms were further analyzed. After 15 minutes, Kv1.3 colocalized with Transferrin Receptor (Trsf-R), which is used as a CCP marker (Fig. 7Aa-Bd) . After 30 minutes of PMA incubation, Kv1.3 was distributed within early endosomes, identified by Early Endosomal Antigen 1 (EEA1) (Fig. 7Ca-Dd) . Finally, 120 minutes of PKC activation targeted Kv1.3 to lysosomes stained with LysoTracker ® Red (Fig. 7Ea-Fd) . Concomitantly, 4 hours of PMA incubation in the presence of 100 μ g/ml CHX triggered a massive decrease of Kv1.3 expression (Fig. 7Ga-Gc) . Further, when also inhibiting lysosomal degradation using the vacuolar-type H + -ATPase inhibitor BafA1 (20 μ M), the rapid PKC-associated decrease in Kv1.3 abundance was halted (Fig. 7H) . Overall, our results suggest that PKC activation, either by ADO or by PMA, triggered a down-regulation of cell-surface Kv1.3 via CCP that targets the channel for lysosomal degradation.
PKC activation induces ubiquitination-dependent Kv1.3 endocytosis mediated by Nedd4-2 ubiquitin ligase activity. Ubiquitin-dependent endocytosis targets channels and transporters to lysosome-dependent degradation 22, 39, 40 . In this context, the E3 ubiquitin ligase Nedd4-2 associates with Kv1.3 and downregulates the activity of the channel 41, 42 . Therefore, we next evaluated whether PKC-dependent Kv1.3 endocytosis, and thus lysosome-dependent degradation, was associated with the channel ubiquitination. PMA triggered a notable PKC-dependent ubiquitination of Kv1.3, which was hampered by BIM (Fig. 8A,B ). Kv1.3 was transiently ubiquitinated upon PMA incubation and exhibited maximum levels at 15-30 minutes (Fig. 8C,D) . Similar to Kv1.3 endocytosis and raft microdomain displacement, PSD-95 protected Kv1.3 against ubiquitination (Fig. 8E,F) . To assess whether Nedd4-2 was involved in Kv1.3 endocytosis via PKC activation, we blocked its expression by using specific siRNA against Nedd4-2 (Fig. 8G ). Kv1.3-YFP HEK cells transfected with Nedd4-2 siRNA were incubated with PMA for 30 min at 37 °C. When Nedd4-2 was depleted, the internalization of Kv1.3 was negligible (Fig. 8H-L ). To definitively demonstrate the role of ubiquitination on the PKC-dependent Kv1.3 endocytosis, we mutated all the intracellular lysines of the channel (Lys70, 80, 146, 270, 342, 467, 476, 498, 519 and 520) to arginines. In the presence of PMA, the Kv1.3(Kless) mutant was not ubiquitinated (Fig. 8M,N) . Relatedly, the internalization of Kv1.3(Kless) was minor upon PMA incubation (Fig. 8O-Q) . Altogether, our results demonstrate that Kv1.3 is ubiquitinated by Nedd4-2 upon PKC-activation, triggering channel endocytosis and lysosome-dependent degradation.
Discussion
Adenosine (ADO), which activates PKC signaling pathways, is an endogenous regulator in many physiological processes 7, 8, 43, 44 . PKC modulates Kv1.3 activity, which is essential for a proper immune response 14, 45 . Furthermore, both proteins are localized in the same membrane platforms, highlighting the importance of PKC-dependent regulation of Kv1.3 in leukocyte physiology 10, 34 . Because Kv1.3 participates in the onset of several immunological diseases 3, 46 , elucidating the mechanism by which ADO-dependent PKC-activation modulates this channel is essential for understanding the immune response. Therefore, we analyzed the PKC-based mechanisms that control the cell-surface levels of Kv1.3 as an efficient way to regulate the function of this ion channel. ADO, activating PKC, initiates a signaling cascade that modulates the cell-surface abundance of Kv1.3 by channel endocytosis. In addition, PSD-95 stabilizes Kv1.3 into lipid raft microdomains and protects the channel against internalization. Kv1.3 endocytosis is a CCP-dependent mechanism that drives the channel to lysosome-associated degradative intracellular compartments and requires previous ubiquitination by the E3 ubiquitin ligase Nedd4-2.
While activation of mononuclear phagocytes increases Kv1.3, anti-inflammatory agents decrease channel expression 14, 16, 47 . ADO, via A 2A and A 2B receptors, is a potent endogenous immunosuppressor 7, 15 , and it decreases Kv1.3 levels in macrophages and dendritic cells. In addition, ADO induced internalization of the channel in HEK-293 cells, leading to PKC-mediated Kv1.3 lysosomal degradation. The presence of fewer channels at the cell surface results in less Kv1.3-driven signaling and thereby leads to immunosuppression in leukocytes 47 . In contrast, an ADO-mediated PKC-dependent mechanism stabilizes Kir6.2 channels at the myocyte plasma membrane 23 . However, PKC activation induces internalization of the epithelial sodium channel (ENaC) and the dopamine transporter (DAT) by the same clathrin-mediated endocytosis (CME) mechanism as Kv1.3 [48] [49] [50] . CME also participates in the Kv1.2 and Kir1.1 endocytic pathways in neurons and renal cells 51, 52 . Our results support that the down-regulation of Kv1.3 would trigger immunosuppression via PKC-dependent CME in leukocytes. This mechanism accelerates the degradation of the channel by targeting it to the lysosomal compartment after PKC-dependent stimulation. We further demonstrated that this process requires direct ubiquitination of Kv1.3 by the E3 ubiquitin ligase Nedd4-2. Recent evidence has shown that Nedd4-2 also drives Kv1.3 toward proteasomal degradation 41 . Thus, efficient Nedd4-2-dependent ubiquitination triggers the down-regulation of Kv1.3 via lysosomes and proteasomes, likely acting as redundant and complementary pathways. PKC activation triggers endocytosis and ubiquitination of proteins such as DAT, the glutamate transporter GLT1, the cationic amino acid transporter CAT-1 and aquaporin-2 (AQP2) 22, 50, 53, 54 . Nedd4-2 downregulates Kv1.3 currents, but no direct ubiquitination of the channel had been demonstrated until now 41, 42 . The absence of a canonical PY motif together with the irrelevance of a SH3 signature and several lysines within the C-terminal domain of Kv1.3 would suggest alternative mechanisms of association 41 . In T-cells and macrophages, Kv1.3 is targeted to lipid raft membrane microdomains, where it is concentrated upon cellular activation 11, 55 . Altered raft-associated Kv1.3 localization in the IS occurs at the onset of the disease lupus erythematosus 38 and a minor raft targeting of Kv1.3 modifies the physiological response 34, 47 . We demonstrated that PKC activation displaced Kv1.3 from lipid rafts, similar to what was described for the transporter NET 56 . However, unlike that of NET, the PKC-dependent endocytosis of Kv1.3 is independent of caveolae/lipid raft internalization. Several ion channels, such as TRPV5 and Kir6.1, use the caveolae-dependent internalization machinery 35, 57 . TRPV5 endocytosis is inhibited by caveolin-1 knockdown 57 . However, similar to the cationic amino acid and dopamine transporters (CAT1 and DAT, respectively), Kv1.3 was internalized via CCP and independently of caveolae/rafts 22, 50 . In this context, the localization of Kv1.3 in and out of rafts would have important physiological consequences. Therefore, recruitment and/or stabilization of the channel at the proper location by accessory proteins, such as caveolins and MAGUKs, would influence the immune response. PKC and Kv1.3 are distributed into lipid raft membrane microdomains within T-lymphocytes, and they are recruited to the IS during T-cell activation 11 . Moreover, PKC and Kv1.3 are part of a signalplex that also includes the tyrosine kinase p56lck, adaptor proteins such as Kvβ 2 and hDlg (human homolog of the Drosophila discs large tumor suppressor protein), PSD-95 (postsynaptic density 95), ZIP-1 (Zrt/Irt-like protein) and ZIP-2, and the accessory protein CD4 58 . This cluster facilitates the phosphorylation of Kv1.3, thereby modulating its function. Our results show that PSD-95 association redistributes Kv1.3 into less-mobile membrane microdomains compatible with lipid rafts. In T-lymphocytes, PSD-95 interacts with Kv1.3, inducing clustering and recruiting Kv1.3 into the IS 37 . Similarly, PSD-95 recruits Kv1.4 into lipid rafts, inhibiting the internalization of Kv1.4 59 . A dynamic partitioning model would explain the behavior of raft proteins, suggesting movements in and out of raft domains in a steady-state equilibrium. This spatial distribution would permit proteins to transiently populate raft domains as well as to undergo diffusion outside of rafts. It is tempting to speculate that Kv1.3 would exit rafts being internalized via CCP during immunosuppression. In fact, Kv1.5, acting as an immunosuppresor, influences Kv1.3 by displacing heteromeric Kv1.3/Kv1.5 channels out of rafts in macrophages 34, 47, 60 . In this scenario, PKC would enhance the exit of Kv1.3 from raft areas and/or facilitate its distribution into clathrin-accessible regions to be endocytosed. In fact, PMA-induced PKC-activation in T-lymphocytes inhibits Kv1.3-dependent K + currents 6 . Therefore, a functional Kv1.3-PSD-95 interaction is required not only for correct Kv1.3 redistribution in the vicinity of IS formation but also to prevent a massive internalization of the channel as a consequence of PKC-dependent immunosuppressive insults.
New treatments targeting inflammation-mediated organ dysfunction associated with autoimmune diseases are worth investigation. After persistent activation, mononuclear phagocytes play a pivotal role, supporting the characterization of ADO as an immunomodulatory agent. Adenoreceptor stimulation attenuates inflammation-mediated damage by down-regulating phagocytic activity and preventing excessive respiratory burst activation. For example, the inflammatory response is partially responsible for the damage associated with 61 . In this respect, selective inhibition of A 2B enhances intestinal inflammation and injury following ischemia/reperfusion, whereas specific A 2B agonist treatment protects against intestinal injury 62 . A 2B receptor agonists reduce myocardial ischemia/reperfusion damage by promoting anti-inflammatory M2 macrophages together with decreases in M1 macrophage and neutrophil infiltration in re-perfused hearts 63 . In this context, Kv1.3 is a viable pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke 64 . Our results shed light on the molecular mechanism underlying the anti-inflammatory function of A 2B agonist therapy via the modulation of Kv1.3.
Methods
Expression plasmids and site-directed mutagenesis. The rat Kv1.3 in the pRcCMV construct was provided by T.C. Holmes (University of California, Irvine, CA). The channel was subcloned into pEYFP-C1 (Clontech). The rKv1.3 construct that was externally tagged with HA between S3 and S4 was obtained from D.B. Arnold (University of Southern California, CA). For some experiments, the HA-Kv1.3 channel was further subcloned into the pEYFP-C1 plasmid, generating the double-tagged HA-Kv1.3-YFP channel. All Kv1.3 mutants were generated in the pEYFP-Kv1.3 channel. Single and multiple Kv1.3 mutants were generated using the QuikChange site-directed and multi-site-directed mutagenesis kits (Stratagene). All mutations were verified using automated DNA sequencing. Myc-PSD-95 was a kind gift from Dr. F. Zafra (Centro de Biología Molecular Severo Ochoa, Madrid).
Cell culture, transfections and incubations. Unless specified, all reagents were purchased from Sigma-Aldrich. HEK-293 and CY15 mouse dendritic cells were cultured in DMEM and RPMI culture medium (Lonza), respectively, supplemented with 10% fetal bovine serum (FBS), 10,000 U/ml penicillin, 100 μ g/ml streptomycin and 2 mM L-glutamine (GIBCO). Murine bone marrow-derived macrophages (BMDM) were isolated and cultured as previously described 14 . HEK-293 cells were incubated with 200 μ M Adenosine (ADO) or 1 μ M phorbol-12-myristate-13-acetate (PMA) in DMEM for the specified times. BMDM and CY15 cells were incubated for 24 h with or without 200 μ M ADO in the presence or the absence of 100 ng/ml of lipopolysaccharide (LPS). Experiments and surgical protocols were performed in accordance with the guidelines approved by the ethical committee of the Universitat de Barcelona and following the European Community Council Directive 86/609 EEC.
Transfection was performed using Metafectene ® Pro (Biontex) at approximately 80% confluence. Kv1.3-YFP experiments in HEK-293 cells were mainly performed using a cell line with stable Kv1.3-YFP expression. Briefly, 24 h after Kv1.3 transfection, cells were cultured in the presence of 500 μ g/ml of G418 (Geneticin) for selection. Geneticin-resistant clones were maintained in the presence of 250 μ g/ml G418. When required, transient transfections were performed 24 h to 48 h before the experiment. For the confocal analyses, cells cultured in the same medium were plated on poly-lysine-coated coverslips. Cells were incubated with 200 μ M ADO or 1 μ M PMA in DMEM for the specified times. DMSO (dilution 1:1,000) was used as a negative control. Cells were washed in PBS (without K Protein extraction, co-immunoprecipitation, raft isolation and western blot analysis. Cells were washed twice in cold PBS before being lysed on ice with NHG solution (1% Triton X-100, 10% glycerol, 50 mmol/L HEPES pH 7.2, 150 mmol/L NaCl) supplemented with 1 μ g/ml aprotinin, 1 μ g/ml leupeptin, 1 μ g/ ml pepstatin and 1 mM phenylmethylsulfonyl fluoride to inhibit proteases. Total lysates were centrifuged at 16,000 × g for 15 min at 4 °C, and the protein content was measured using the Bio-Rad Protein Assay (Bio-Rad).
Samples were precleared with 30 μ l of protein G-Sepharose beads for 2 h at 4 °C with gentle mixing as part of the co-immunoprecipitation procedures. Beads were removed by centrifugation at 1,000 × g for 30 s at 4 °C. Samples were incubated overnight with the specified antibody (4 ng/μ g protein) at 4 °C with gentle agitation. Next, 30 μ l of protein G-Sepharose 4 fast flow (GE Healthcare) was added to each sample, and the samples were incubated for 4 h at 4 °C. Beads were removed by centrifugation at 1,000 × g for 30 s at 4 °C, washed four times in NHG, and resuspended in 80 μ l of SDS sample buffer.
Protein samples (50 μ g) and immunoprecipitates were boiled in Laemmli SDS loading buffer and separated using 10% SDS-PAGE. Next, samples were transferred to nitrocellulose membranes (Immobilon-P, Millipore) and blocked in PBS supplemented with 5% dry milk and 0.05% Tween-20 before the immunoreaction. The filters were immunoblotted with antibodies against Kv1.3 (1/200, NeuroMab), iNOS (1/200, Santa Cruz), HA (1/200, Sigma), GFP (1/1,000, Roche), myc (1/1,000, Sigma), PAN-caveolin (1/250, BD Bioscience), clathrin heavy chain (1/500, BD Bioscience), dynamin II (1/1,000, ABR), total PKC (1/500, Santa Cruz), phosphorylated PKCε (1/200, Santa Cruz) and ubiquitin and Nedd4-2 (1/1,000, Santa Cruz) and β -actin (1/50,000, Sigma).
Lipid raft isolation was performed as previously described 34 . Briefly, samples were homogenized in MES (2-Morpholino ethanesulfonic acid)-buffered saline (24 mM MES, pH 6.5, and 0.15 mM NaCl) plus 1% Triton X-100 and centrifuged at 3,000 g for 5 min at 4 °C. Next, sucrose was added to achieve a final concentration of 40%. A 5-30% linear sucrose gradient was layered on top and further centrifuged (39,000 rpm) for 20-22 h at 4 °C in a Beckman SW41 Ti swinging bucket rotor. Gradient fractions (1 ml) were collected from the top and analyzed by Western blot.
Confocal microscopy and subcellular compartment identification. Cells fixed with 4% paraformaldehyde in PBS for 10 min were further permeabilized using 0.1% Triton X-100 for 10 min. After a 60 min incubation with a blocking solution (PBS, 10% goat serum, 5% non-fat dry milk), cells were incubated for 60 min with anti-Clathrin (clathrin heavy chain, 1/100, BD Bioscience), anti-α subunit of AP2 (Adaptor-related Protein complex 2, 1/500, AP.6, American Type Culture Collection), anti-Transferrin receptor (1/1,000, Abcam) or anti-EEA1 (Early Endosomal Antigen 1, 1/1,000, BD Bioscience) in PBS, 10% goat serum and 0.05% Triton. For the extracellular distribution of HA-Kv1.3-YFP, cells were incubated with anti-HA (1/1,000, Sigma) under non-permeabilizing conditions. Next, cells were further incubated for 45 min with an Alexa Fluor secondary antibody (1:500, Molecular Probes) in PBS and BSA (2%). All experiments were performed at 21-23 °C (RT). In some experiments, cells were washed with PBS at 4 °C and stained with LysoTracker ® red (1/1,000, Molecular Probes) for 30 min at 4 °C. Staining with FITC-labeled cholera toxin β subunit (CTXβ ) for lipid raft microdomains was performed under non-permeabilized conditions. Cells washed with PBS were stained with FITC-CTXβ for 30 min at 4 °C. Subsequently, cells were washed and fixed as above. Cells were examined with a 63x oil immersion objective on a Leica TCS SL laser-scanning confocal microscope. All offline image analyses were performed using a Leica confocal microscope, Image J software and Sigma Plot. The level of endocytosis was quantified analyzing the number of intracellular vesicle accumulation by using the automatic particle counting protocol of the Image J software and setting threshold around 75% to discard the membrane surface mask. siRNA transfections. Synthetic siRNAs for Clathrin, dynamin II and the missense negative control (Mock) were purchased from Dharmacon. Duplexes were resuspended in 1x siRNA universal buffer (Dharmacon) to 20 μ M. HEK-293 cells expressing the stable Kv1.3-YFP channel were grown in six-well plates to 50% confluence. Cells were transfected with siRNA duplexes to a final concentration of 120 nM in 5 μ l DharmaFECT1 reagent (Dharmacon, Inc). After 36 h, a second transfection was performed, and the cells were replated into 12-well plates on the following day for internalization experiments. The efficiency of knockdown was evaluated by Western blotting. Mock-and siRNA-transfected cells were processed for immunofluorescence as described above.
Antibody-feeding endocytosis assay. Cells grown on glass coverslips were incubated with 1-2 μ g/ml of anti-HA11 (1/1,000, Covance) in DMEM for 30-60 min at RT, washed twice and incubated at 37 °C in the presence or in the absence of 1 μ M PMA for 30 min. The cells were then washed with ice-cold Ca 2+ /Mg 2+ -free PBS (CMF-PBS) and fixed with freshly prepared 4% paraformaldehyde for 8 min at room temperature. Cells were stained with secondary anti-mouse antibody conjugated with Cy5 (5 μ g/ml, saturating concentration) in CMF-PBS containing 0.5% BSA at RT for 60 min to occupy surface HA11. After washings, the cells were permeabilized by 10 min of incubation in CMF-PBS containing 0.1% Triton X-100 at RT and then incubated with the same secondary antibody conjugated with Cy3 (1 μ g/ml, non-saturating concentration) for 60 min to stain internalized HA11. Both primary and secondary antibody solutions were precleared by centrifugation at 100,000 × g for 20 min. After staining, cells were washed, and the coverslips were mounted in Mowiol (Calbiochem).
Electrophysiology. Whole-cell currents were recorded using the patch-clamp technique in the whole-cell configuration with a HEKA EPC10 USB amplifier (HEKA Elektronik). PatchMaster software (HEKA) was used for data acquisition. We applied a stimulation frequency of 50 kHz and a filter at 10 kHz. The capacitance and series resistance compensation were optimized. In most experiments, we obtained an 80% compensation of the effective access resistance. Micropipettes were made from borosilicate glass capillaries (Harvard Apparatus) using a P-97 puller (Sutter Instrument) and fire polished. The extracellular solution contained the following (in mM): 136 NaCl, 4 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 10 D-glucose, pH 7.4. CY15 cells were clamped to a holding potential of − 60 mV. To evoke voltage-gated currents, cells were stimulated with 250 ms square pulses ranging from -60 to + 80 mV in 10 mV steps. The peak amplitude (pA) was normalized using the capacitance values (pF). Data analysis was performed using FitMaster (HEKA) and Sigma Plot 10.0 software (Systat Software). All recordings were performed at RT.
Statistics.
Statistical analysis was performed where indicated by means of One-Way or Two-Way ANOVA with Tukey or Bonferroni post-test respectively, Mann-Whitney U test or Student t test by using GraphPad Prism 5 (Graphpad Software Inc.).
